|
| |
Corgenix, Inc., and Corgenix UK specialize in the development, manufacturing, and
worldwide marketing of numerous products for the medical diagnostic industry.
Since its inception in 1990, Corgenix has demonstrated a strong and continued
growth in this market and has a formidable reputation as an innovative provider
of healthcare products. Our menu of over 140 diagnostic products is sold on a
worldwide basis to hospitals, clinical laboratories, commercial reference
laboratories, and research institutions. Corgenix (formally REAADS, see History)
was the first commercial company in the United States to develop and manufacture
the anticardiolipin assay used in the detection of a number of autoimmune and
vascular diseases. Since 1990 the Corgenix product line has grown to include
products used in the diagnosis of these important areas of healthcare: autoimmune
disease, vascular disease, infectious disease, and liver disease.
|
